The Report Guru

The global spatial genomics and transcriptomics market is expected to grow from USD 355 million in 2022 to USD 800 million by 2027, exhibiting a robust CAGR of 17.6%. This growth is primarily driven by the increasing adoption of spatial genomics and transcriptomics techniques in drug discovery and development. Additionally, the rise in research and development investments and public-private funding, along with the introduction of technologically advanced instruments, are propelling market expansion. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 Understanding Market Dynamics Spatial Transcriptomics Techniques Lead the Market The spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2021, spatial transcriptomics techniques accounted for the largest share of the global market. This growth is attributed to their high adoption in drug discovery and...

According to research report the global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the increasing development in the area such as neurodegenerative diseases and cancer. Along with this, launch of several advanced products are contributing towards the growth of the market. On the other hand, need of high initial investments, and dearth of skilled professionals are some factors limiting the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The market for spatial genomics & transcriptomics is highly consolidated, with key players strategizing to capture the market. Prominent players in the market are NanoString Technologies, Inc. (US), 10X Genomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic V...